Presence of Tissue Transglutaminase in Granular Endoplasmic Reticulum is Characteristic of Melanized Neurons in Parkinson's Disease Brain

Department of Anatomy and Neurosciences, Neuroscience Campus Amsterdam, VU University Medical Center, the Netherlands.
Brain Pathology (Impact Factor: 3.84). 03/2011; 21(2):130-9. DOI: 10.1111/j.1750-3639.2010.00429.x
Source: PubMed


Parkinson's disease (PD) is characterized by the accumulation of α-synuclein aggregates and degeneration of melanized neurons. The tissue transglutaminase (tTG) enzyme catalyzes molecular protein cross-linking. In PD brain, tTG-induced cross-links have been identified in α-synuclein monomers, oligomers and α-synuclein aggregates. However, whether tTG and α-synuclein occur together in PD affected neurons remains to be established. Interestingly, using immunohistochemistry, we observed a granular distribution pattern of tTG, characteristic of melanized neurons in PD brain. Apart from tTG, these granules were also positive for typical endoplasmic reticulum (ER)-resident chaperones, that is, protein disulphide isomerase, ERp57 and calreticulin, suggesting a direct link to the ER. Additionally, we observed the presence of phosphorylated pancreatic ER kinase (pPERK), a classical ER stress marker, in tTG granule positive neurons in PD brain, although no subcellular colocalization of tTG and pPERK was found. Our data therefore suggest that tTG localization to granular ER compartments is specific for stressed melanized neurons in PD brain. Moreover, as also α-synuclein aggregates were observed in tTG granule positive neurons, these results provide a clue to the cellular site of interaction between α-synuclein and tTG.

Download full-text


Available from: Micha Wilhelmus, Oct 03, 2015
21 Reads
  • Source
    • "In addition, no colocalization of anti-tTG antibody immunoreactivity with the pathologic lesions characteristic of ADdin particular, senile plaques (SPs), cerebral amyloid angiopathy (CAA), and neurofibrillary tangles (NFTs)dwas observed. On the basis of their findings, Wolf and colleagues concluded that, in contrast to many previous reports including those from our group (Appelt et al., 1996; Bonelli et al., 2002; Citron et al., 2002; Dudek & Johnson, 1993; Johnson et al., 1997; Kim et al., 1999; Miller & Anderton, 1986; Miller & Johnson, 1995; Nemes et al., 2004; Norlund et al., 1999; Selkoe, 2002; Selkoe et al., 1982a, 1982b; Singer et al., 2002; Wang et al., 2008; Wilhelmus et al., 2009, 2011a, 2011b, 2012b; Zhang et al., 1998), tTG is not present in the brain, apart from blood vessels, and is also not associated with the pathologic lesions of AD, in particular SPs, CAA and NFTs. In the discussion section of the article, they suggested that their relatively long postmortem delay differs from the other reports that did find colocalization of tTG with SPs, CAA, and NFTs (Appelt et al., 1996; Citron et al., 2002; de Jager et al., 2013; Dudek & Johnson,1993; Johnson et al.,1997; Kim et al.,1999; Miller & Johnson, 1995; Nemes et al., 2004; Norlund et al., 1999; Selkoe et al., 1982a; Singer et al., 2002; Wilhelmus et al., 2009, 2012b; Zhang et al., 1998) and that this might explain the fact that no association of tTG with the pathological hallmarks of AD was found. "
    Neurobiology of Aging 04/2014; 35(4):e3–e4. DOI:10.1016/j.neurobiolaging.2013.08.022 · 5.01 Impact Factor
  • Source
    • "As such, it is also involved in the folding of newly synthesized proteins and glycoproteins and, together with calnexin (an integral ER membrane chaperone) and PDIA3 (ERp57, an ER protein of 57 kDa; a PDI (protein disulfide-isomerase)-like ER-resident protein), it constitutes the 'calreticulin/calnexin cycle that is responsible for folding and quality control of newly synthesized glycoproteins. In fact, during recent years, CALR has been implicated to play a pivotal role in many biological systems, including functions inside and outside of the ER, indicating that the protein is a multi-process molecule (Gelebart et al., 2005; Gold et al., 2010; Michalak et al., 2009) that might be involved as an ER-resident chaperone in AD and PD (Kudo et al., 2008; Lai et al., 2009; Wilhelmus et al., 2011). PDIA3 itself is an ERresident thiol-disulfide oxidoreductase which is modulating STAT (signal transducer and activator of transcription, also affected upon tianma treatment) signaling from the lumen of the ER together with CALR (Chichiarelli et al., 2010; Coe et al., 2010) that might be affected by PD (Kim-Han and O'Malley, 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Tianma (Rhizoma gastrodiae) is the dried rhizome of the plant Gastrodia elata Blume (Orchidaceae family). As a medicinal herb in traditional Chinese medicine (TCM) its functions are to control convulsions, pain, headache, dizziness, vertigo, seizure, epilepsy and others. In addition, tianma is frequently used for the treatment of neurodegenerative disorders though the mechanism of action is widely unknown. Accordingly, this study was designed to examine the effects of tianma on the proteome metabolism in differentiated human neuronal SH-SY5Y cells to explore its specific effects on neuronal signaling pathways. Using an iTRAQ (isobaric tags for relative and absolute quantitation)-based proteomics research approach, we identified 2390 modulated proteins, out of which 406 were found to be altered by tianma in differentiated human neuronal SH-SY5Y cells. Based on the observed data, we hypothesize that tianma promotes neuro-regenerative signaling cascades by controlling chaperone/proteasomal degradation pathways (e.g. CALR, FKBP3/4, HSP70/90) and mobilizing neuro-protective genes (such as AIP5) as well as modulating other proteins (RTN1/4, NCAM, PACSIN2, and PDLIM1/5) with various regenerative modalities and capacities related to neuro-synaptic plasticity.
    Neurochemistry International 06/2012; 60(8):827-36. DOI:10.1016/j.neuint.2012.03.012 · 3.09 Impact Factor
  • Source
    • "The aggregation of particular proteins in the brain, however, is thought to be a contributing factor in a number of important neurodegenerative disorders. Examples include aβ in the amyloid plaques of AD (Zhang et al. 1998, Wilhelmus et al. 2009), α-synuclein in the Lewy bodies of PD (Junn et al. 2003, Nemes et al. 2004, Segers-Nolten et al. 2008, Nemes et al. 2009, Verhaar et al. 2011, Wilhelmus et al. 2011), and huntingtin in the inclusion bodies of HD (Gentile et al. 1998, Kahlem et al. 1998, Cooper et al. 2002, Dedeoglu et al. 2002, Karpuj et al. 2002, Zainelli et al. 2003, Zainelli et al. 2005) (for a comprehensive list of these proteins see (Kim et al. 2002, Hoffner et al. 2010)). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Transglutaminases catalyze the formation of γ-glutamylamines utilizing glutamyl residues and amine-bearing compounds such as lysyl residues and polyamines. These γ-glutamylamines can be released from proteins by proteases in an intact form. The free γ-glutamylamines can be catabolized to 5-oxo-L-proline and the free amine by γ-glutamylamine cyclotransferase. Free γ-glutamylamines, however, accumulate in the CSF and affected areas of Huntington Disease brain. This observation suggests transglutaminase-derived γ-glutamylamines may play a more significant role in neurodegeneration than previously thought. The following monograph reviews the metabolism of γ-glutamylamines and examines the possibility that these species contribute to neurodegeneration.
    Amino Acids 03/2012; 44(1). DOI:10.1007/s00726-011-1209-3 · 3.29 Impact Factor
Show more